| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 37 |
| 1 | CARBOPLATIN | 17 |
| 2 | PACLITAXEL | 11 |
| 3 | PACLITAXEL (AIBUMIN-BOUND) | 10 |
| 4 | CYCLOPHOSPHAMIDE | 8 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 8 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 8 |
| 7 | NIVOLUMAB | 8 |
| 8 | PREGABALIN | 7 |
| 9 | ALLOPURINOL | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TOCILIZUMAB-AAZG | 1 | 0.0016 |
| 1 | LISOCABTAGENE MARALEUCEL | 1 | 0.0011 |
| 2 | APREPITANT | 6 | 0.0008 |
| 3 | EPIRUBICIN HYDROCHLORIDE | 3 | 0.0005 |
| 4 | FOSAPREPITANT DIMEGLUMINE | 6 | 0.0004 |
| 5 | PEMBROLIZUMAB | 37 | 0.0003 |
| 6 | PEGFILGRASTIM | 2 | 0.0002 |
| 7 | TIGECYCLINE | 1 | 0.0002 |
| 8 | PEMETREXED DISODIUM | 6 | 0.0002 |
| 9 | CARBOPLATIN | 17 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 6 | 0.0007 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 45 | 0.0005 |
| 2 | Tetracycline-class Antibacterial [EPC] | 1 | 0.0001 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 4 | 0.0001 |
| 4 | Microtubule Inhibitor [EPC] | 11 | 0.0001 |
| 5 | Platinum-based Drug [EPC] | 18 | 0.0001 |
| 6 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 7 | Bile Acid [EPC] | 1 | 0.0000 |
| 8 | Xanthine Oxidase Inhibitor [EPC] | 6 | 0.0000 |
| 9 | Alkylating Drug [EPC] | 8 | 0.0000 |